BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2011
View Archived Issues
Phase I/II trial assesses gene therapy in X-linked chronic granulomatous disease / News in Context
Read More
ADOPT study compares apixaban and enoxaparin in medically ill patients
Read More
Selvita describes novel pim and haspin kinase inhibitors
Read More
Kowa begins long-term phase III trial of potential glaucoma treatment in Japan
Read More
Mitsubishi Tanabe Pharma presents highlights of second quarter of fiscal year 2011
Read More
Novel apoptosis inhibitors patented by Chinese PLA General Hospital
Read More
GlaxoSmithKline presents new AMPK activators
Read More
Companies collaborate on spinal muscular atrophy research
Read More
Novel orexin receptor antagonists emerge from R&D at Evotec
Read More
Kyoto Pharmaceutical describes new indoline derivatives
Read More
Hippocampal markers of stress susceptibility identified
Read More
FDA accepts Onyx Pharmaceuticals' NDA for carfilzomib
Read More
New indazoles with antiproliferative and/or apoptosis-inducing activity identified
Read More
Civitas Therapeutics receives Michael J. Fox Foundation grant to develop CVT-301
Read More
New anticancer compounds described by Merck & Co.
Read More
PET and MRI can be used to asses a marker of nociceptive activity
Read More
Advinus Therapeutics completes proof-of-concept study of GKM-001
Read More
Alnylam completes enrollment in phase IIb ALN-RSV01 study
Read More
Targovax to receive grant for phase II/III cancer vaccine study
Read More
Omthera Pharmaceuticals completes enrollment in EVOLVE study
Read More
Marina Biotech and Debiopharm select lead formulation for bladder cancer program
Read More
Talon Therapeutics enrolls first patient in phase III Marqibo study
Read More
Ablynx's phase I/II study of ALX-0061 advances
Read More
Merrimack Pharmaceuticals begins phase I study of MM-121 with multiple anticancer therapies
Read More
Dainippon Sumitomo Pharma files application in Japan for combination antihypertensive product
Read More
Idera Pharmaceuticals regains global rights to IMO-2055
Read More
Dainippon Sumitomo Pharma and Yoshitomiyakuhin to terminate antipsychotic drug copromotion agreement
Read More